Search

everythinglearnresearchcommunity

for

Search:↓

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

The conclusion is that proper signaling is crucial for hair growth and development, and errors can lead to cancer or hair loss.

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Eye exams are crucial for kids with 13q deletion syndrome, tamoxifen can cause vision loss, Propecia may lead to cataracts, Lipoid Proteinosis causes skin bumps, and OCT is useful for diagnosing macular diseases.

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

Taking Propecia might lead to the development of cataracts.

Androgens can both increase body hair and cause scalp hair loss.

Finasteride, often used for hair loss, can potentially cause cataracts.

The document concludes that careful diagnosis is crucial for chromosome 13q deletion syndrome, tamoxifen can cause reversible eye damage, finasteride may be linked to cataracts, and OCT is useful for diagnosing macular diseases.

Multiple eye conditions were studied, highlighting the importance of various imaging methods for diagnosis, the vision side effects of drugs tamoxifen and Propecia, and the usefulness of optical coherence tomography for diagnosing and monitoring macular and retinal diseases.

Finasteride and minoxidil are effective, low-risk treatments for male hair loss, and patient education on these therapies is important.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Cow milk sugars increase fat production and inflammation in skin oil cells.

The BMP/Smads pathway and Id2 gene control hair follicle stem cells, affecting their rest and growth phases.

Scientists created a tiny, 3D model of a hair follicle that grows and acts like a real one.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

Nanostructured delivery systems could potentially improve hair loss treatment by targeting drugs to hair follicles, reducing side effects and dosage, but the best size, charge, and materials for these systems need further investigation.

Growth hormone levels affect hair growth and loss, with too much causing excess hair and too little leading to hair loss.

Rare genetic variants in five specific genes are linked to male-pattern hair loss but only account for a small part of the risk.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Minoxidil effectively treats hair loss, but use cautiously and monitor side effects.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Psychotropic drugs can cause hair loss or excessive hair growth.

Hair loss in men is common, treatable, but not curable.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.